14. Chronic inflammatory demyelinating polyneuropathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24
Chronic inflammatory demyelinating polyneuropathy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 14 | Chronic inflammatory demyelinating polyneuropathy |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 11 | Myasthenia gravis |
| 6 | Parkinson disease |
| 12 | Congenital myasthenic syndrome |
| 50 | Dermatomyositis |
| 3 | Spinal muscular atrophy |
| 222 | Primary nephrotic syndrome |
| 28 | Systemic amyloidosis |
| 49 | Systemic lupus erythematosus |
| 4 | Primary lateral sclerosis |
| 83 | Addison disease |
| 61 | Autoimmune hemolytic anemia |
| 331 | Idiopathic multicentric castleman disease |
| 66 | IgA nephropathy |
| 60 | Aplastic anemia |
| 65 | Primary immunodeficiency |
| 85 | Idiopathic interstitial pneumonia |
| 96 | Crohn disease |
| 2 | Amyotrophic lateral sclerosis |
| 46 | Malignant rheumatoid arthritis |
| 43 | Microscopic polyangiitis |
| 300 | IgG4-related disease |
| 44 | Wegener granulomatosis |
| 35 | Pemphigus |
| 52 | Mixed connective tissue disease |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |